NCT06596694: An ongoing trial by Merck Sharp & Dohme LLC
This trial is ongoing. It must report results 3 years, 11 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06596694 |
|---|---|
| Title | A Phase 1/2 Study to Evaluate the Safety and Efficacy of Patritumab Deruxtecan in Gastrointestinal Cancers |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 3, 2024 |
| Completion date | Dec. 7, 2028 |
| Required reporting date | Dec. 7, 2029, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |